This document lists numerous lectures and panels presented by the author over several years on topics related to healthcare reform, innovation, biologics, biosimilars, and reimbursement. The events include discussions at industry conferences, government briefings and meetings, universities, and business organizations. The panels explored issues including the impact of healthcare reform on innovation, frameworks for competition between brand and generic biologics, and perspectives on reimbursement and cost-effectiveness.